Interactions between human mesenchymal stem cells and natural killer cells.
about
Clinical applications of mesenchymal stem cellsImmunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetesEffects of Oxidative Stress on Mesenchymal Stem Cell BiologyMesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Mesenchymal stem cells (MSCs) as skeletal therapeutics - an updateMesenchymal Stem Cell-Mediated Effects of Tumor Support or SuppressionSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsMesenchymal Stromal Cells Affect Disease Outcomes via Macrophage PolarizationManagement of fibrosis: the mesenchymal stromal cells breakthroughConcise review: clinical translation of wound healing therapies based on mesenchymal stem cellsImmunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cellsConsequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursorsMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusHuman mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applicationsImmunobiology of mesenchymal stem cellsStem cell treatment for Alzheimer's diseaseRecent progress toward understanding the physiological function of bone marrow mesenchymal stem cellsImmunoregulation by mesenchymal stem cells: biological aspects and clinical applicationsThe Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent CellsImmunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activityPharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cellsBone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 productionImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyStromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie's DiseaseImmune mechanisms and novel pharmacological therapies of acute kidney injury.Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease.Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium.Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity.Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Adipose-derived mesenchymal stem cells modulate CD14++CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2.Characterization of Fetal Tissue-derived Mesenchymal Stem Cells.Cytokine secretion profiling of human mesenchymal stem cells by antibody array.Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicityFunction and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?Influence of immune responses in gene/stem cell therapies for muscular dystrophies.
P2860
Q21198864-DCD25664-FE8A-44D6-8F02-293B4F2D49DCQ24644691-A1765950-95E2-4292-985C-DEAE51218C27Q26740408-E2599071-DEF2-4B15-9CA8-5A8A712002FEQ26741252-C9CE8D6E-4B9B-4714-BFAE-E34D68335D7AQ26746104-71D43DF0-C16F-4E98-98B1-C765117DF33EQ26753086-70C2F9E5-9704-4A05-A834-694996062971Q26773413-D196CA72-7849-4FD8-A96E-9170FCBFD8C5Q26799916-01017173-79FA-4637-B55E-2822AD03DDFEQ26800098-016DC6B8-09F1-4B23-A89D-362A2798359EQ26827231-85E68271-B4BC-4885-B9D0-5DFD820D8F72Q26830539-5D4FD5AE-E64A-4A86-9C63-DA73A23A578FQ26852467-A7963C7C-4FDB-4C1E-A5A0-287316C53137Q26864483-C1B064B1-06F0-4ED7-AFD1-D439B8E2BDD6Q26864580-6ABF2175-D5D0-4327-B267-F7F782FA2AB7Q27004008-D5519AC6-F476-472A-AE96-54AE0AEC70C0Q27004487-2FF7A50A-AA27-46B0-9287-3D94469EFA91Q27007013-78FF5B80-9228-432D-9D22-4BAC960C6C40Q27007493-A4178EBC-B5DC-4EE8-953F-B115CA8BE8CDQ27026892-B12BC586-151C-4EE8-A511-1E0EA5A93C8BQ28074203-29495A02-F4A8-4F2E-9723-3A44FC021C11Q28084829-7B7B7485-BA4D-4736-A773-E0AC174940FEQ28484341-E6C58850-ECFD-47D3-9C9F-C999BEE5B307Q28540077-A583F9F3-B0A1-47B5-8578-987DD11FE60BQ29619807-0CB490D3-D553-4356-959E-E3F22C3DE052Q29994669-79737900-5DD2-4920-A4F3-8EB4ECD94BC4Q30382162-D2F7DF6A-F665-434C-AA5D-87C4D7F486C3Q30434767-E30AF2B0-D30B-4BA0-9CF0-C601E1E685E0Q30585387-18FADA14-F691-439A-A8D5-0517A9CE40FDQ30853758-9E193D6A-F6F7-4415-86E6-5A9BEB72FC3BQ30980207-C87E2307-2E11-4FA5-9CBF-4C064505484CQ33403795-E3072E9A-A9F4-40F8-BEBE-1C3CDE6A9430Q33570359-82E2E67A-FED1-4AEB-9DE4-57302FCB44DBQ33608585-593098EF-C2AA-4329-99AD-351E9CF0DF61Q33614836-705FBF8C-3501-4FCF-AADF-80754967C72BQ33614842-0B9FC920-1AB8-48B4-AFFD-B419B0097CFDQ33653621-18F6C673-867A-4698-B96E-B63F52D123DCQ33698636-5093371E-B09F-4E71-8B3E-C8F367433F5CQ33710719-21050368-15B3-49F1-9BC3-D38EEF81E6ECQ33712984-1BB06C4D-0DEE-41CF-A6D0-6F5815AB6345Q33736192-43D88B82-770D-4256-82B5-9783E52C3D99
P2860
Interactions between human mesenchymal stem cells and natural killer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interactions between human mesenchymal stem cells and natural killer cells.
@en
type
label
Interactions between human mesenchymal stem cells and natural killer cells.
@en
prefLabel
Interactions between human mesenchymal stem cells and natural killer cells.
@en
P2093
P1433
P1476
Interactions between human mesenchymal stem cells and natural killer cells.
@en
P2093
Angelos D Gritzapis
Constantin N Baxevanis
Michael Papamichail
Panagiota A Sotiropoulou
Sonia A Perez
P356
10.1634/STEMCELLS.2004-0359
P577
2005-08-11T00:00:00Z